Gloed Heer Groenland rela nf kappa b amyotrophic lateral sclerosis pubmed Veel Diagnostiseren blaas gat
NF‐κB activation in astrocytes drives a stage‐specific beneficial neuroimmunological response in ALS | The EMBO Journal
Purinergic P2X7 Receptor: A Therapeutic Target in Amyotrophic Lateral Sclerosis | ACS Chemical Neuroscience
IJMS | Free Full-Text | Heterogeneity of Neuroinflammatory Responses in Amyotrophic Lateral Sclerosis: A Challenge or an Opportunity?
Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion?
GSK-3β controls NF-kappaB activity via IKKγ/NEMO | Scientific Reports
IJMS | Free Full-Text | The Links between ALS and NF-κB
State of play in amyotrophic lateral sclerosis genetics | Nature Neuroscience
Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers | Nature Reviews Neurology
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury | Cell Death & Disease
Symptoms timeline and outcomes in amyotrophic lateral sclerosis using artificial intelligence | Scientific Reports
Stress Granule Homeostasis, Aberrant Phase Transition, and Amyotrophic Lateral Sclerosis | ACS Chemical Neuroscience
Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis - The Lancet Neurology
Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model | Scientific Reports
Frontiers | Key Disease Mechanisms Linked to Amyotrophic Lateral Sclerosis in Spinal Cord Motor Neurons
TAZ ameliorates the microglia-mediated inflammatory response via the Nrf2-ROS-NF-κB pathway: Molecular Therapy - Nucleic Acids
Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis | Journal of Medicinal Chemistry
Cells | Free Full-Text | The NF-κB Pathway and Cancer Stem Cells
Gene therapy for ALS: A review: Molecular Therapy
Frontiers | Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis
Cells | Free Full-Text | Aberrant Activation of NF-κB Signalling in Aggressive Lymphoid Malignancies
Frontiers | Protective role of ethyl pyruvate in spinal cord injury by inhibiting the high mobility group box-1/toll-like receptor4/nuclear factor-kappa B signaling pathway
Frontiers | Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease
Cells | Free Full-Text | Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System
Frontiers | The Safety and Efficacy of Stem Cell Therapy as an Emerging Therapy for ALS: A Systematic Review of Controlled Clinical Trials